STAA - STAAR Surgical Company logo

STAAR Surgical Company

STAA

STAAR Surgical Company designs, manufactures, and sells phakic implantable lenses and delivery systems for vision correction. Its products, including the EVO ICL family, target myopia, hyperopia, astigmatism, and presbyopia, serving healthcare providers globally.

βš•οΈ Healthcare NASDAQ Listed 1983 $ USD
$1,000 invested 30 years ago β†’$1,560today

Score Overview

1 Year
Score
Net Growth104.77%
Net TrendGrew
Net Income Consistencyβ€”
Rev Growth41.83%
Rev TrendGrew
Revenue Consistencyβ€”
5 Years
Score4.0
Net Growth-86.05%
Net Trend40%
Net Income Consistencyβ€”
Rev Growth47.35%
Rev Trend60%
Revenue Consistencyβ€”
10 Years
Score
Net Growth131.65%
Net Trend60%
Net Income Consistency
Rev Growth311.96%
Rev Trend80%
Revenue Consistency
20 Years
Score4.9
Net Growth125.52%
Net Trend50%
Net Income Consistency
Rev Growth6x
Rev Trend85%
Revenue Consistency
30 Years
Score
Net Growth-44.36%
Net Trend46%
Net Income Consistency
Rev Growth8x
Rev Trend77%
Revenue Consistency
All Time
Score
Net Growth201.03%
Net Trend47%
Net Income Consistency
Rev Growth49x
Rev Trend74%
Revenue Consistency

Explore the 2021 public Archive ranking β†’

Where STAAR Surgical Company has ranked, year by year

Measure
Fundamentals Window

Showing 30 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • STAA

2019: 82.5% Β· 2021: 81.0% Β· free through 2021 Β· longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 20.87β€”
1 Year2025-09-26
$ 26.80-22.13%
5 Years2021-09-28
$ 128.99-83.82%
10 Years2016-09-28
$ 9.28124.89%
20 Years2006-09-28
$ 7.68171.74%
30 Years1996-09-27
$ 13.3856.04%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 339M$ 3M$ 181M
2025$ 239M-$ 80M$ 187M
2024$ 313M-$ 20M$ 230M
2023$ 322M$ 21M$ 220M
2022$ 284M$ 39M$ 211M
2021$ 230M$ 27M$ 199M
2020$ 163M$ 5M$ 152M
2019$ 150M$ 14M$ 119M
2018$ 123M$ 4M$ 103M
2017$ 90M-$ 2M$ 18M
2016$ 82M-$ 12M$ 13M
2015$ 77M-$ 6M$ 13M
2014$ 74M-$ 8M$ 13M
2013$ 72M$ 398K$ 22M
2012$ 63M-$ 1M$ 21M
2011$ 62M$ 1M$ 16M
2010$ 54M$ 9M
2009$ 75M-$ 6M$ 6M
2008$ 74M-$ 23M$ 5M
2007$ 59M-$ 15M$ 11M
2006$ 56M-$ 15M$ 7M
2005$ 51M-$ 11M$ 12M
2004$ 51M-$ 11M$ 9M
2003$ 50M-$ 8M$ 7M
2002$ 48M-$ 17M$ 1M
2001$ 50M-$ 14M$ 853K
2000$ 53M-$ 18M$ 6M
1999$ 59M$ 2M$ 3M
1998$ 54M$ 2M$ 4M
1997$ 42M$ 7M$ 6M
1996$ 42M$ 6M$ 6M
1995$ 34M$ 7M$ 3M
1994$ 27M$ 8M$ 3M
1993$ 20M$ 2M$ 1M
1992$ 10M-$ 5M$ 1M
1991$ 4M-$ 11M$ 2M
1990$ 4M$ 3M$ 700K
1989$ 4M-$ 4M
1988$ 6M-$ 3M$ 100K
STAA - STAAR Surgical Company logo

STAAR Surgical Company fundamental performance

Between 2015 and 2025, revenue grew from $ 77M to $ 239M and net income went from -$ 6M to -$ 80M. Revenue increased in 8 of those 10 years; net income in 6.

Between 2005 and 2025, revenue grew from $ 51M to $ 239M and net income went from -$ 11M to -$ 80M. Revenue increased in 17 of those 20 years; net income in 10.

STAAR Surgical Company currently holds a 20-year HDB Score of 4.9 out of 10. How the HDB Score is calculated.

Membership

Continue STAA’s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year Β· Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies